Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Help & FAQ
Link opens in a new tab
Search content at Houston Methodist Scholars
Home
Experts
Research units
Research output
Prizes
Bifidobacterium animalis spp. lactis
Eamonn Martin Quigley
Charles W. Duncan Jr. Department of Medicine
Academic Institute
Underwood Center for Digestive Health
Houston Methodist Hospital
Houston Methodist
Weill Cornell Medical College
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
10
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bifidobacterium animalis spp. lactis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lactis
100%
Bifidobacterium Animalis
100%
Commercially Available
50%
Immune Response
50%
Clinically Significant
50%
Oxidative Stress
50%
Colon
50%
Fermented Milk Products
50%
Immune Regulation
50%
Irritable Bowel Syndrome
50%
Symptom Relief
50%
Gastrointestinal Diseases
50%
Constipation
50%
Gut Barrier Function
50%
Acid Stress
50%
Milk
50%
Lactis BB-12
50%
Resistance to Acid
50%
Gut Transit
50%
Milk Culture
50%
Medicine and Dentistry
Gut
100%
Bifidobacterium animalis
100%
Immune Response
50%
Colon
50%
Irritable Bowel Syndrome
50%
Immunomodulation
50%
Oxidative Stress
50%
Constipation
50%
Gastrointestinal Distress
50%
Agricultural and Biological Sciences
Bifidobacterium
100%
Grand Unified Theory
100%
Oxidative Stress
50%
Colon
50%
Immune Response
50%
Immunomodulation
50%
Fermented Milk
50%
Immunology and Microbiology
Bifidobacterium animalis
100%
Oxidative Stress
50%
Immune Response
50%
Colon
50%
Immunomodulation
50%
Pharmacology, Toxicology and Pharmaceutical Science
Bifidobacterium animalis
100%
Irritable Colon
50%
Gastrointestinal Symptom
50%
Constipation
50%
Food Science
Bifidobacterium animalis
100%
Fermented Milk Products
50%